Newcastle upon Tyne, United Kingdom

Roger John Griffin

USPTO Granted Patents = 20 


 

Average Co-Inventor Count = 9.1

ph-index = 6

Forward Citations = 81(Granted Patents)


Location History:

  • Handsworth Wood, Birmingham B20 2AB, GB (1991)
  • Morpeth, GB (2001 - 2010)
  • Newcastle Upon Tyne, GB (2006 - 2010)
  • Tyne, GB (2012)
  • Northumberland, GB (2013)
  • Lancaster Park, GB (2016 - 2019)
  • London, GB (2019 - 2021)
  • (2020 - 2022)

Company Filing History:


Years Active: 1991-2022

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Roger John Griffin in Cancer Research

Introduction: Roger John Griffin, a prominent inventor based in Newcastle upon Tyne, GB, has made significant strides in the field of cancer research with a remarkable portfolio of 20 patents. His pioneering work focuses on developing innovative compounds that target critical interactions involved in cancer progression.

Latest Patents: Among his latest patents, Griffin has developed isoindolinone inhibitors that affect the MDM2-P53 interaction and exhibit anticancer activity. The invention encompasses a compound of formula (I), or its tautomer, a solvate, or a pharmaceutically acceptable salt thereof. These compounds hold great promise for pharmaceutical compositions, highlighting processes for their synthesis and various medical applications.

Career Highlights: Griffin's impressive career includes key roles at Cancer Research Technology Limited and Kudos Pharmaceuticals Limited. His expertise has been instrumental in advancing cancer treatments and enhancing the understanding of tumor biology.

Collaborations: Throughout his career, Griffin has collaborated with esteemed professionals in the field, including Bernard Thomas Golding and Ian Robert Hardcastle. These collaborations have further enriched his research efforts and contributed to groundbreaking developments in cancer therapeutics.

Conclusion: Roger John Griffin's dedication to cancer research and his innovative contributions continue to play a vital role in the development of effective treatments. His extensive patent portfolio reflects his commitment to enhancing the medical field and improving patient outcomes in cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…